BioSpace News Archive

Biotech Investor Event to Explore Latest NASH Developments and Controversies in Facilitated Company Discussions

The 2019 HLTH Conference is being held October 27- 30 at the MGM Grand Convention Center in Las Vegas.

SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced that Pete O’Heeron, SpinalCyte’s Chief Executive Officer, will present at the BIO Investor Forum on Tuesday, October 22, 2019 at 3:45 p.m. PDT in San Francisco, CA.

Shenango is a continuing care retirement community/life plan community located in New Wilmington, PA.

The findings run counter to recommendations from professional societies and is based on results from a randomized clinical trial that included 1,500 survivors of acute coronary syndromes.

Grants Will Streamline Access to Benefits for Five Million People Living in Poverty by 2025

Proprietary platform recapitulates neuroinflammatory signature from Alzheimer’s Disease patients Data presented at Society for Neuroscience 49th Annual Meeting

October is Breast Cancer Awareness Month, with its signature wearing of pink to help build awareness of prevention and treatment of the disease.

A new study in rats shows the extent of brain damage in newborn rodents from even short-term abuse by their mother.

Dalian Fusheng Pharmaceutical Company Co., Ltd., a major pharmaceutical company in Dalian, China has contributed $100,000 to the Milstein Medical Asian American Partnership Foundation to support translational research at Johns Hopkins University focusing on aging immune system and viral infections.